Antibiotika Evi 2012

download Antibiotika Evi 2012

of 42

Transcript of Antibiotika Evi 2012

  • 8/12/2019 Antibiotika Evi 2012

    1/42

    2008

    ANTIBIOTIKAEvi Umayah Ulfa

  • 8/12/2019 Antibiotika Evi 2012

    2/42

    Antimicrobial Drugs

    Chemotherapy The use of drugs to treat adisease

    Antimicrobial drugs Interfere with the growth ofmicrobes within a host

    Antibiotic Substance produced by amicrobe that, in small amounts,inhibits another microbe

    Selective toxicity A drug that kills harmful microbes

    without damaging the host

  • 8/12/2019 Antibiotika Evi 2012

    3/42

  • 8/12/2019 Antibiotika Evi 2012

    4/42

    Table 20.1

    MicrobialSources of

    Antibiotics

  • 8/12/2019 Antibiotika Evi 2012

    5/42

    Table 20.2

    Antibiotic Spectrum of Activity

    No antibiotic is effective against all microbes

  • 8/12/2019 Antibiotika Evi 2012

    6/42

    Mode of Antimicrobial Action

    Bacteria have their own enzymes for

    Cell wall formation

    Protein synthesis

    DNA replication

    RNA synthesis

    Synthesis of essential metabolites

  • 8/12/2019 Antibiotika Evi 2012

    7/42

    Mode of Antimicrobial Action

    Figure 20.2

  • 8/12/2019 Antibiotika Evi 2012

    8/42

    Inhibition of Cell Wall Synthesis

  • 8/12/2019 Antibiotika Evi 2012

    9/42

  • 8/12/2019 Antibiotika Evi 2012

    10/42

    Beta Lactam Antibiotics (Penicillins)

    B-lactams inhibittranspeptidase.

    Only effective againstrapidly growing organismsthat synthesizepeptidoglycan. (Ineffectiveagainst mycobacteria.)

  • 8/12/2019 Antibiotika Evi 2012

    11/42

    Penicillin

    Penicilinase-resistant penicillins

    Extended-spectrum penicillins

    Penicillins + -lactamase inhibitors

    Carbapenems

    Monobactam

    Inhibitors of Cell Wall Synthesis

  • 8/12/2019 Antibiotika Evi 2012

    12/42

    Inhibitors of Cell Wall Synthesis

    Figure 20.8

    Cincin beta laktam AB penisilin dirusak oleh enzim penisilinase

  • 8/12/2019 Antibiotika Evi 2012

    13/42

    Cephalosporins

    2nd, 3rd, and 4th

    generations moreeffective against

    gram-negatives

    Antibacterial AntibioticsInhibitors of Cell Wall Synthesis

    Figure 20.9

  • 8/12/2019 Antibiotika Evi 2012

    14/42

    Polypeptide antibiotics

    Bacitracin

    Topical application

    Against gram-positives

    Inhibits regeneration of phospholipids receptorsinvolved in peptidoglycan synthesis.

    Vancomycin Glycopeptide

    Important "last line" against antibiotic resistant S.aureus

    Inhibitors of Cell Wall Synthesis

  • 8/12/2019 Antibiotika Evi 2012

    15/42

    Antimycobacterium antibiotics

    Isoniazid (INH)

    Inhibits mycolic acid synthesis Ethambutol

    Inhibits incorporation of mycolic acid

    Inhibitors of Cell Wall Synthesis

  • 8/12/2019 Antibiotika Evi 2012

    16/42

    Inhibition of Protein Synthesis (Translation)

    Figure 20.4

  • 8/12/2019 Antibiotika Evi 2012

    17/42

    Chloramphenicol Broad spectrum

    Binds 50S subunit, inhibits peptide bondformation

    Aminoglycosides

    Streptomycin, neomycin, gentamycin

    Broad spectrum

    Changes shape of 30S subunit

    Inhibitors of Protein Synthesis

  • 8/12/2019 Antibiotika Evi 2012

    18/42

    Tetracyclines Broad spectrum

    Interferes with tRNA attachment

    Macrolides Gram-positives

    Binds 50S, prevents translocation

    Erythromycin

    Gram-positives

    Binds 50S, prevents translocation

    Inhibitors of Protein Synthesis

  • 8/12/2019 Antibiotika Evi 2012

    19/42

    Polymyxin B

    Bacillus polymyxa(PolimixinA,B,C, and D)

    Decapeptide that disrupts the phospholipidlayer incell membrane

    Topical

    Combined with bacitracin and neomycin in over-

    the-counter preparation

    Injury to the Plasma Membrane

  • 8/12/2019 Antibiotika Evi 2012

    20/42

    Rifamycin Inhibits RNA synthesis

    Antituberculosis

    Quinolones and fluoroquinolones (DNA Synthesis) Ciprofloxacin

    Inhibits DNA gyrase

    Urinary tract infections

    Inhibitors of Nucleic Acid Synthesis

  • 8/12/2019 Antibiotika Evi 2012

    21/42

    Sulfonamides (Sulfa drugs)

    Inhibit folic acid synthesis

    Broad spectrum

    Inhibitions of Sythesis os Essential Metabolites

    Figure 5.7

  • 8/12/2019 Antibiotika Evi 2012

    22/42

    Figure 20.13

    Inhibitions of Sythesis os Essential Metabolites

  • 8/12/2019 Antibiotika Evi 2012

    23/42

    Classes of Antibiotics

    Lactam AB

    Macrolide AB

    Tetracyclines

    Aminoglycoside AB

    Polypeptide AB

    Lyncosamide

    Chloramphenicol

    Rifamycins

    Minor AB

  • 8/12/2019 Antibiotika Evi 2012

    24/42

    Polyenes

    Amphotericin B Azoles

    Miconazole

    Triazoles Allylamines

    Antifungal DrugsInhibition of Ergosterol Synthesis

    Figure 20.15

  • 8/12/2019 Antibiotika Evi 2012

    25/42

    Echinocandins

    Inhibit synthesis of -glucan

    Cancidas is used against Candida andPneumocystis

    Antifungal DrugsInhibition of Cell Wall Synthesis

  • 8/12/2019 Antibiotika Evi 2012

    26/42

    Flucytocine

    Cytosine analog interferes with RNA synthesis

    Pentamidine isethionate

    Anti-Pneumocystis; may bind DNA

    Antifungal DrugsInhibition of Nucleic Acids

  • 8/12/2019 Antibiotika Evi 2012

    27/42

    Griseofulvin

    Used for superficial mycoses

    Tolnaftate

    Used for athlete's foot; action unknown

    Antifungal DrugsInhibition of Microtubules (Mitosis)

  • 8/12/2019 Antibiotika Evi 2012

    28/42

    Antiviral DrugsNucleoside and Nucleotide Analogs

    Figure 20.16a

  • 8/12/2019 Antibiotika Evi 2012

    29/42

    Antiviral DrugsNucleoside and Nucleotide Analogs

    Figure 20.16b, c

  • 8/12/2019 Antibiotika Evi 2012

    30/42

    Protease inhibitors Indinavir

    HIV

    Inhibit attachment

    Zanamivir

    Influenza

    Inhibit uncoating

    Amantadine Influenza

    Interferons prevent spread of viruses to new cells

    Viral hepatitis

    Antiviral DrugsEnzyme Inhibitors

  • 8/12/2019 Antibiotika Evi 2012

    31/42

    Chloroquine Inhibits DNA synthesis

    Malaria

    Metronidazole Damages DNA

    Entamoeba, Trichomonas

    Antiprotozoan Drugs

  • 8/12/2019 Antibiotika Evi 2012

    32/42

    A ih l i hi

  • 8/12/2019 Antibiotika Evi 2012

    33/42

    Mebendazole

    Inhibits nutrient absorption

    Intestinal roundworms

    Ivermectin

    Paralyzes worm

    Intestinal roundworms

    Antihelminthic Drugs

    Di k Diff i T

  • 8/12/2019 Antibiotika Evi 2012

    34/42

    Disk-Diffusion Test

    Figure 20.17

    Metode untukmenguji kepekaan

    AB

    E TMetode untuk

  • 8/12/2019 Antibiotika Evi 2012

    35/42

    E Test

    Figure 20.18

    Metode untuk

    menguji kepekaan

    AB

    B h Dil i TMetode untuk

  • 8/12/2019 Antibiotika Evi 2012

    36/42

    Broth Dilution Test

    Figure 20.19

    Metode untuk

    menguji kepekaan

    AB

    Hasil Uji Kepekaan Antibiotik

  • 8/12/2019 Antibiotika Evi 2012

    37/42

    Diameter Hambat

    MIC Minimal inhibitory concentration

    Kadar minimal AB yang mampu menghambatMO

    MBC Minimal bactericidal concentration

    Kadar Minimal AB yang mampu membunuhMO

    Hasil Uji Kepekaan Antibiotik

    A tibi ti R i t

  • 8/12/2019 Antibiotika Evi 2012

    38/42

    A variety of mutations can lead to antibiotic resistance.

    Mechanisms of antibiotic resistance

    1. Enzymatic destruction of drug

    2. Prevention of penetration of drug

    3. Alteration of drug's target site

    4. Rapid ejection of the drug

    Resistance genes are often on plasmids or

    transposons that can be transferred between bacteria.

    Antibiotic Resistance

    A tibi ti R i t

  • 8/12/2019 Antibiotika Evi 2012

    39/42

    Misuse of antibiotics selects for resistance mutants.

    Misuse includes:

    Using outdated, weakened antibiotics

    Using antibiotics for the common cold and other

    inappropriate conditions

    Use of antibiotics in animal feed

    Failure to complete the prescribed regimen

    Using someone else's leftover prescription

    Antibiotic Resistance

    Eff t f C bi ti f D

  • 8/12/2019 Antibiotika Evi 2012

    40/42

    Synergism occurs when the effect of two drugs

    together is greater than the effect of either alone.

    Antagonism occurs when the effect of two drugs

    together is less than the effect of either alone.

    Effects of Combinations of Drugs

    Eff t f C bi ti f D

  • 8/12/2019 Antibiotika Evi 2012

    41/42

    Effects of Combinations of Drugs

    Figure 20.22

    Th F t f Ch th ti A t

  • 8/12/2019 Antibiotika Evi 2012

    42/42

    Antimicrobial peptides

    Broad spectrum antibiotics from plants and animals

    Squalamine (sharks)

    Protegrin (pigs)

    Magainin (frogs)

    Antisense agents

    Complementary DNA or peptide nucleic acids thatbinds to a pathogen's virulence gene(s) and

    prevents transcription

    The Future of Chemotherapeutic Agents